Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 17 August 2009, doi:10.1136/bmj.b3016
Cite this as: BMJ 2009;339:b3016
Zoe Morris, senior clinical fellow in neuroradiology1, William N Whiteley, CSO clinical academic fellow1, W T Longstreth, Jr, professor of neurology and epidemiology2, Frank Weber, consultant neurologist3, Yi-Chung Lee, attending physician4, Yoshito Tsushima, associate professor of diagnostic radiology5, Hannah Alphs, medical student6, Susanne C Ladd, consultant radiologist7, Charles Warlow, emeritus professor of medical neurology1, Joanna M Wardlaw, professor of applied neuroimaging1,8, Rustam Al-Shahi Salman, MRC clinician scientist and honorary consultant neurologist1
1 Division of Clinical Neurosciences, Western General Hospital, Edinburgh EH4 2XU, 2 Departments of Neurology and Epidemiology, Harborview Medical Center, Seattle, WA, USA, 3 German Air Force Institute of Aviation Medicine, Department of Neurology, Fuerstenfeldbruck, Germany, 4 Department of Neurology, Taipei Veterans General Hospital, Taiwan, 5 Department of Diagnostic Radiology and Nuclear Medicine, Gunma University Hospital, Japan, 6 Department of Radiology and Radiological Sciences, Johns Hopkins Hospital, Baltimore, MD, USA, 7 Department of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Germany, 8 SFC Brain Imaging Research Centre, University of Edinburgh
Correspondence to: R Al-Shahi Salman Rustam.Al-Shahi{at}ed.ac.uk
Design Systematic review and meta-analysis of observational studies.
Data sources Ovid Medline (1950 to May 2008), Embase (1980 to May 2008), and bibliographies of relevant articles.
Review methods Two reviewers sought and assessed studies of people without neurological symptoms who underwent MRI of the brain with or without intravenous contrast for research purposes or for occupational, clinical, or commercial screening.
Main outcome measures Overall disease specific and age specific prevalence of incidental brain findings, calculated by meta-analysis of pooled proportions using DerSimonian-Laird weights in a random effects model.
Results In 16 studies, 135 of 19 559 people had neoplastic incidental brain findings (prevalence 0.70%, 95% confidence interval 0.47% to 0.98%), and prevalence increased with age (
2 for linear trend, P=0.003). In 15 studies, 375 of 15 559 people had non-neoplastic incidental brain findings (prevalence 2.0%, 1.1% to 3.1%, excluding white matter hyperintensities, silent infarcts, and microbleeds). The number of asymptomatic people needed to scan to detect any incidental brain finding was 37. The prevalence of incidental brain findings was higher in studies using high resolution MRI sequences than in those using standard resolution sequences (4.3% v 1.7%, P<0.001). The prevalence of neoplastic incidental brain findings increased with age.
Conclusions Incidental findings on brain MRI are common, prevalence increases with age, and detection is more likely using high resolution MRI sequences than standard resolution sequences. These findings deserve to be mentioned when obtaining informed consent for brain MRI in research and clinical practice but are not sufficient to justify screening healthy asymptomatic people.
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-nc/2.0/ and http://creativecommons.org/licenses/by-nc/2.0/legalcode.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?
Read all Rapid Responses